KNOBELMAN DEBORAH (Chief Financial Officer) received a stock award from KRONOS BIO, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 6/4/2024ACC: 0001415889-24-015398
Officer· Chief Financial Officer
Since Jun 2024
+410.65K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
410.65K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+164.26K
Price / share
—
Trade value
—
% of position
New position
6/3/2024
0.00→164.26K
Total
Net shares
+164.26K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/3/2024 | A · Award | +164.26K | — | — | New position | 0.00 | 164.26K |
| Total | +164.26K | $0.00 | ||||||
Derivative Transactions1
Employee Stock Option (Right to Buy)
Direct
Converts to
Common Stock
246.39K shares
Shares
+246.39K
Strike price
0.745
Held after
246.39K
Exercisable
—
6/3/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy) Direct | Common Stock246.39K shares | 6/3/2024 | A · Award | +246.39K | 0.745 | — | 246.39K |